Nexus Capital Investments files 13D after buying 79.6% stake in BioForce
Nexus Capital Investments, Inc. disclosed in a Schedule 13D that it acquired a 79.6% stake in BioForce NanoSciences Holdings, Inc.’s common stock. The position was disclosed on Sep. 04, 2026 after a private purchase completed Apr. 22, 2026.
Nexus Capital Investments, Inc. said it acquired a 79.6% stake in BioForce NanoSciences Holdings, Inc.’s common stock. The position was disclosed in a Schedule 13D filed on Sep. 04, 2026, after a private purchase completed on Apr.
22, 2026. The transaction involved 26.7 million shares bought for $400.